1. Practice guidelines based on clinical and economic evidence

   • Frans Rutten
   • Werner Brouwer
   • Louis Niessen

   Editorial Pages: 91 - 93

2. Costs of hospitalization for severe acute asthma of patients not treated according to guidelines and recommendations

   • Jean-Claude Sailly
   • Xavier Lenne
   • Isabelle Tillie-Leblond

   ❚ Pages: 94 - 101

3. Cost of home palliative care compared with conventional hospital care for patients with haematological cancers in Greece

   • Sofia Tzala
   • Joanne Lord
   • Evangelia Tzala

   Original papers Pages: 102 - 106

4. Time preference bias in time trade-off

   • Marjon van der Pol
   • Larissa Roux

   Original papers Pages: 107 - 111

5. Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany

   • Uwe Siebert
   • Gaby Sroczynski
   • Siegbert Rossol

   Original Papers Pages: 112 - 123

   

6. Validating the EQ-5D with time trade off for the German population

   • W. Greiner
   • C. Claes
   • J.-M. Graf von der Schulenburg

   Original papers Pages: 124 - 130

7. Spatial competition for quality in the market for hospital care

   • Marcello Montefiori

   Original Papers Pages: 131 - 135

   

8. Cost-effectiveness of venlafaxine XL compared with diazepam in the treatment of generalised anxiety disorder in the United Kingdom

   • J. F. Guest
   • J. Russ
   • A. Lenox-Smith

   Original Papers Pages: 136 - 145

   

9. Order bias in estimates of willingness to pay for drugs to treat attention-deficit/hyperactivity disorder

   • Annemieke De Ridder
   • Diana De Graeve

   Original Papers Pages: 146 - 151

10. Risk and potential risk reduction in diabetes type 2 patients in Germany

    • Bertram Häussler
    • Ursula Berger
    • Wolfgang Thefeld

    ❚ Pages: 152 - 158

    

11. Economic burden of hepatitis C in Canada and the potential impact of prevention

    • Susie El Saadany
    • Douglas Coyle
    • Mohammad Afzal

    ❚ Pages: 159 - 165

    

12. The direct medical cost of diabetes in Israel

    • Gabriel Chodick
    • Anthony D. Heymann
    • Ehud Kokia

    Original Papers Pages: 166 - 171

    

13. The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation

    • Christophe Legendre
    • Stephen M. Beard
    • Isabelle Durand-Zaleski

    Original Papers Pages: 172 - 182

    

14. German health care system in transition

    • J.-Matthias Graf von der Schulenburg

    Pricing and reimbursement Pages: 183 - 187